16:17 EST Denali Therapeutics (DNLI) files automatic mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DNLI:
- Denali Therapeutics initiated with a Buy at Deutsche Bank
- Denali Therapeutics announces primary analysis of Phase 1/2 study in MPS II
- Denali Therapeutics Outlines 2025 Milestones and Strategies
- Denali Therapeutics announces U.S. FDA BTD granted for tividenofusp
- Denali recent pullback a buying opportunity, says Jefferies